CHEN BIHUA (CEO and Chairperson) reported 4 transactions at BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/6/2026ACC: 0001213900-26-075538
DirectorOfficer10% Owner· CEO and Chairperson
Since Feb 2024
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
4.53M acquired · 4.53M disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−4.53M
Price / share
—
Trade value
—
% of position
New position
7/1/2026
4.53M→0.00
Common Stock
Indirect
Shares
+2.69M
Price / share
—
Trade value
—
% of position
123.1%
7/1/2026
2.19M→4.88M
Common Stock
Indirect
Shares
+1.70M
Price / share
—
Trade value
—
% of position
51.6%
7/1/2026
3.31M→5.01M
Common Stock
Indirect
Shares
+130.87K
Price / share
—
Trade value
—
% of position
2.2%
7/1/2026
5.95M→6.08M
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/1/2026 | J · J | −4.53M | — | — | New position | 4.53M | 0.00 |
| Common Stock Indirect | 7/1/2026 | J · J | +2.69M | — | — | 123.1% | 2.19M | 4.88M |
| Common Stock Indirect | 7/1/2026 | J · J | +1.70M | — | — | 51.6% | 3.31M | 5.01M |
| Common Stock Indirect | 7/1/2026 | J · J | +130.87K | — | — | 2.2% | 5.95M | 6.08M |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.91M
Total
1.91M indirect1.91M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.91M | Indirect |
| Total | 1.91M | 1.91M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported